×

CXCR4 agonist treatment of hemapoietic cells

  • US 20020165123A1
  • Filed: 04/12/2001
  • Published: 11/07/2002
  • Est. Priority Date: 04/12/2000
  • Status: Abandoned Application
First Claim
Patent Images

1. A method of reducing the rate of hematopoietic cell multiplication, comprising administering an effective amount of a CXCR4 agonist to the hematopoietic cells.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×